tiprankstipranks
XBiotech announces enrollment completion of Phase I trial for Hutrukin
PremiumThe FlyXBiotech announces enrollment completion of Phase I trial for Hutrukin
1y ago
XBiotech announces enrollment completion of Phase II study for Natrunix
Premium
The Fly
XBiotech announces enrollment completion of Phase II study for Natrunix
1y ago
XBiotech treats first patient in Phase II RA trial of Natrunix
Premium
The Fly
XBiotech treats first patient in Phase II RA trial of Natrunix
1y ago
XBiotech announces first subject enrollment in Phase I trial for Hutrukin
PremiumThe FlyXBiotech announces first subject enrollment in Phase I trial for Hutrukin
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100